Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201202062 Principal Investigator: Schroeder, Mark
Title: A phase 1b study to evaluate the safety and preliminary Efficacy of pf-04449913, an oral hedgehog inhibitor, in Combination with intensive chemotherapy, low dose ara-c or Decitabine in patients with acute myeloid leukemia or high risk Myelodysplastic syndrome
Phase: I Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this research study is to learn about the effects of the study drug, PF-04449913, in combination with chemotherapy, and to find the best dose of PF-04449913 for treating AML and high risk MDS.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)